Welcome
BioInvent is a research-based pharmaceutical company developing innovative antibody drugs to target diseases with unmet clinical need. The Company's pipeline currently includes product candidates for the treatment of cancer, thrombosis and atherosclerosis.
Meet us
Kempen & Co Life Sciences Conference 2010:
Mar 23, 2010, Brussels, Belgium.
Carnegie Nordic Health Care Seminar: Mar 24, 2010,
Stockholm, Sweden.
2010 BIO International Convention: May 3-6, 2010,
Chicago, IL, US.
Jeffries Global Life Sciences Conference
2010: Jun 8-11, 2010, N.Y.C., NY, US.
Our Pipeline
BioInvent develops antibody-based drugs to tackle conditions where there is a significant need for new treatments. We currently have four antibody therapeutics in development. Find out more »
Latest Company News
Latest Share Price
Clinical Trials
BioInvent is currently running a number of early-stage clinical trials with several of its products. Click here to find out more »